RSS Feed for Latest Medical Headlines on RxPG News

Medical Research Health Special Topics World

 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
   Insulin Resistance
 Infectious Diseases
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Latest Research : Endocrinology : Diabetes : NIDDM
  Last Updated: Nov 2, 2013 - 11:52:55 AM

Latest Research : Endocrinology : Diabetes : NIDDM
Data support role for adult spleen cells in regeneration of beta cells
New data published in the Nov. 24 issue of Science provide further support for a protocol to reverse type 1 diabetes in mice and new evidence that adult precursor cells from the spleen can contribute to the regeneration of beta cells. In 2001 and 2003, researchers at Massachusetts General Hospital (MGH) demonstrated the efficacy of a protocol to reverse of type 1 diabetes in diabetic mice. Three studies from other institutions published in the March 24, 2006 issue of Science confirmed that the MGH-developed protocol can reverse the underlying disease but were inconclusive on the role of spleen cells in the recovery of insulin-producing pancreatic islets. The new data from a study performed at the National Institutes of Health (NIH), published as a technical comment, provides additional confirmation of the ability to reverse type 1 diabetes and on the role of the spleen cells in islet regeneration.
Nov 24, 2006 - 10:42:30 PM

Latest Research : Endocrinology : Diabetes : NIDDM
Researchers reveal mechanisms behind Thiazolidinediones in type 2 diabetes
Thiazolidinediones (TZD's) are drugs commonly prescribed to patients with type 2 diabetes, the most common form of diabetes. Current U.S. Food and Drug Administration-approved agents are known as Actos (pioglitazone) and Avandia (rosiglitazone). These oral agents improve blood glucose levels in people with diabetes by improving insulin action in the body. While it is known that these drugs work primarily by binding to a receptor in the nucleus of cells called Peroxisome Proliferator Activated Receptor-gamma (PPARg), all of the molecular signaling events important for the drugs to work are not completely understood.
Mar 11, 2006 - 12:51:00 AM

Latest Research : Endocrinology : Diabetes : NIDDM
High-fat diet supresses GnT-4a activity to cause type 2 diabetes
Howard Hughes Medical Institute researchers have discovered a molecular link between a high-fat, Western-style diet, and the onset of type 2 diabetes. In studies in mice, the scientists showed that a high-fat diet disrupts insulin production, resulting in the classic signs of type 2 diabetes. In an article published in the December 29, 2005, issue of the journal Cell, the researchers report that knocking out a single gene encoding the enzyme GnT-4a glycosyltransferase (GnT-4a ) disrupts insulin production. Importantly, the scientists showed that a high-fat diet suppresses the activity of GnT-4a and leads to type 2 diabetes due to failure of the pancreatic beta cells.
Dec 30, 2005 - 3:41:00 PM

Latest Research : Endocrinology : Diabetes : NIDDM
Low blood glucose levels may complicate gastric bypass surgery
Physicians monitoring patients who have undergone gastric bypass surgery should be on the alert for a new, potentially dangerous hypoglycemia (low blood glucose) complication that, while rare, may require quick treatment, according to a new study by collaborating researchers at Joslin Diabetes Center, Beth Israel Deaconess Medical Center (BIDMC), and Brigham and Women's Hospital (BWH) and published in the October issue of the journal Diabetologia. The paper follows on the heels of a Mayo Clinic report on six similar case studies published in July in the New England Journal of Medicine. About 160,000 people undergo gastric bypass surgery every year.
Oct 25, 2005 - 1:56:00 PM

Latest Research : Endocrinology : Diabetes : NIDDM
Muraglitazar found to increase adverse cardiovascular events
A new medication under review by the Food and Drug Administration that may regulate blood glucose levels and have a beneficial effect on blood cholesterol and lipid levels for patients with Type 2 diabetes appears to increase the risk for major adverse cardiovascular events and death, according to a new study in JAMA. The study and an accompanying editorial were released early online at because of their timeliness and potential importance for public health.
Oct 25, 2005 - 5:05:00 AM

Latest Research : Endocrinology : Diabetes : NIDDM
Insulin's role in blocking release of energy
Chronically high levels of insulin, as is found in many people with obesity and Type II diabetes, may block specific hormones that trigger energy release into the body, according to researchers at the University of California, San Diego (UCSD) School of Medicine.
Sep 22, 2005 - 4:51:00 AM

Latest Research : Endocrinology : Diabetes : NIDDM
TORC2 - Key regulator of blood glucose levels discovered
In many patients with type 2 diabetes, the liver acts like a sugar factory on overtime, churning out glucose throughout the day, even when blood sugar levels are high. Scientists at the Salk Institute for Biological Studies discovered a key cellular switch that controls glucose production in liver cells.
Sep 10, 2005 - 11:14:00 PM

Latest Research : Endocrinology : Diabetes : NIDDM
Panel Recommends Muraglitazar for the Treatment of Type 2 Diabetes
Bristol-Myers Squibb and Merck & Co., Inc. jointly announced today that the U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted to recommend approval of PARGLUVA(TM) (muraglitazar), the companies' investigational oral medicine for the treatment of type 2 diabetes, for use as monotherapy and in combination with metformin. The committee voted not to recommend its use in combination with a sulfonylurea.
Sep 10, 2005 - 10:27:00 PM

Latest Research : Endocrinology : Diabetes : NIDDM
Persons at risk for type 2 diabetes have lower rate of cellular energy production
The rate of insulin-stimulated energy production is significantly reduced in the muscles of lean, healthy young adults who have already developed insulin resistance and are at increased risk of developing diabetes later in life, according to a Yale School of Medicine study.
Sep 5, 2005 - 1:41:00 PM

Latest Research : Endocrinology : Diabetes : NIDDM
Sirt1 protein enhances the secretion of Insulin
Opening the possibility of new therapies for type 2 diabetes, researchers at Washington University School of Medicine in St. Louis have found that a protein called Sirt1 enhances the secretion of insulin in mice and allows them to better control blood glucose levels. Their study will appear in the August 17 issue of Cell Metabolism.
Aug 18, 2005 - 2:23:00 AM

<< prev next >>

Gathering information about food is not top priority for individuals with high metabolisms
NIH renews funding for University of Maryland vaccine research
DHA-enriched formula in infancy linked to positive cognitive outcomes in childhood
New IOM report lays out plan to determine effectiveness of obesity prevention efforts
Vitamin D supplementation may delay precocious puberty in girls
Study: Pedometer program helps motivate participants to sit less, move more
Fish oil may stall effects of junk food on brain
Intake of low energy dense food better than skipping meals
Inaugural IOF Olof Johnell Science Award presented to Professor Harry Genant
Molecular hub links obesity, heart disease to high blood pressure
Healthcare experts from UK and India meet at the UK Parliament to discuss ways to improve health care in India, UK
Flu pandemic infected one in five
Stigma preventing leprosy-cured from getting jobs
Measles, Mumps make a comeback in US
Melinda Gates calls on Akhilesh Yadav
'Movies, TV impact tobacco users more than newspapers'
Rockland to open three new hospitals in NCR
Spice Global enters healthcare business with hospital in Delhi
Delhi to expedite recruitment of doctors
India adds spice to US life, keeps it healthy
Latest Research  
How do consumers see a product when they hear music?
Drug activates virus against cancer
Bone loss associated with increased production of ROS
Sound preconditioning prevents ototoxic drug-induced hearing loss in mice
Crystal methamphetamine use by street youth increases risk of injecting drugs
Johns Hopkins-led study shows increased life expectancy among family caregivers
Moderate to severe psoriasis linked to chronic kidney disease, say experts
Licensing deal marks coming of age for University of Washington, University of Alabama-Birmingham
Simple blood or urine test to identify blinding disease
Physician job satisfaction driven by quality of patient care
Medical News  
NHRC issues notice to Kerala over infant deaths
Advanced breast cancer detecting machine comes to India
'Dispel myths about vitiligo'
NHRC summons Odisha chief secretary
Woman dies of swine flu in UP
Maharashtra, GE to modernise rural health care
Hypertension: India's silent killer
Need cautious effort to eradicate polio: Experts
Ayurveda experts develop online personalised health regimen
Soon a detailed study on 'diabesity': Doctors
Special Topics  
MPs express anguish at Delhi gang-rape, Shinde assures fast trial
Worrying rise in number of medical students in prostitution over last 10 years
Behold India's unfolding democratic revolution
Chinese woman cuts open her belly to save surgery cost
Improved Sense of Smell Produced Smarter Mammals
Two-year-old world's first to have extra DNA strand
172,155 kidney stones removed from one patient!
'Primodial Soup' theory for origin of life rejected in paper
Human species could have killed Neanderthal man
History, geography also seem to shape our genome

All rights reserved by RxPG
Contact Us